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Abstract 
Genetic variants in the brain-derived neurotrophic factor (BDNF) gene, predominantly 
the functional Val66Met polymorphism, have been associated with risk of bipolar disorder and 
other  psychiatric  disorders.  However,  not  all  studies  support  these  findings,  and  overall  the 
evidence for BDNF association with disease risk is weak. As differences in population genetic 
structure between patient samples could cause discrepant or spurious association results, we 
investigated this possibility by carrying out population genetic analyses of the BDNF genomic 
region. Substantial variation was detected in BDNF coding region SNP allele and haplotype 
frequencies between 58 global populations, with the derived Met allele of Val66Met ranging 
from  0-72%  frequency  across  populations.  FST a n a l y s e s  to  assess  diversity  in  the  HapMap 
populations determi ned that the Val 66Met F ST val ue was at the 99.8th percenti l e among al l  
SNPs  in  the  genome.  As  the  BDNF p o p u l a t i o n  g e n e t i c  d i f f e r e n c e s  m a y  b e  d u e  t o  l o c a l  
selection,  we  performed  the  long-range  haplotype  (LRH)  test  for  selection  using  68  SNPs 
spanning the BDNF genomic region in 12 European-derived pedigrees. Evidence for positive 
selection  was  found  for a  h i g h  f r e q u e n c y  V a l -carrying  haplotype,  with  a  relative  extended 
haplotype homozygosity (REHH) value above the 99
th percentile compared to HapMap data 
(P=4.6 x 10
-4). In conclusion, we observed considerable BDNF allele and haplotype diversity 
among  global  populations  and  evidence  for  positive  selection  at  the  BDNF l o c u s .  T h e s e  
phenomena can have a profound impact on detection of disease susceptibility genes and must 
be considered in gene association studies of BDNF. 
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Introduction 
Brain-derived  neurotrophic  factor  (BDNF)  is  a  key  neurotrophic  factor  important  for 
neuronal development, survival,  and plasticity
1,2.  A non-synonymous  polymorphism i n BDNF 
that leads to a valine to methionine change at position 66 of the proBDNF protein, referred to as 
Val66Met, has been shown to have an important role in neuronal and cognitive function
3-10. 
BDNF i s i mpl i cat ed as a genet i c r i sk f act or  f or  sever al  psychi at ric  disorders.  We previously 
reported overrepresentation of the Val allele of the Val66Met polymorphism and lower frequency 
of a Met-carrying haplotype in BP patients
11. Val66Met association with BP has received mixed 
support in subsequent studies (Table S1). A meta-analysis we performed using data from 14 
case-control  and  parent-proband  trio  studies d e t e c t e d  modest  but  statistically  significant 
evidence for BDNF association with BP (P = 0.004)
12. BDNF variants have also been associated 
with other psychiatric disorders including obsessive-compulsive disorder
13-15, schizophrenia
16-19, 
psychosis
20, major depression
21, anxiety
22, and eating disorders
23-26. Lack of association has 
also been reported for many of these disorders, however, raising the question of whether BDNF 
is in fact a disease susceptibility gene.  
One explanation for discrepant association findings is differences in population genetic 
structure between patient samples. Isolation between human populations over generations has 
resulted in genetic differentiation marked by allele frequency and linkage disequilibrium (LD) 
differences. Thus, a single population may not accurately reflect variation in other populations, 
and  within  the  same  population  some  members  may  not  be  representative  of  others.  Such 
differences  could  have  a  profound  impact  on  detection  of  disease  risk  genes b e c a u s e  
association  studies  examine  a  fraction  of  gene  polymorphisms,  and  rely  extensively  on  LD 
between markers and susceptibility alleles to detect disease associations. Furthermore, if LD 
patterns vary dramatically between groups, population specific haplotypes will arise that could 
explain  conflicting  association  results.  Thus,  assessment  of  the d i s t r i b u t i o n  o f  p o l y m o r p h i c  Running title: BDNF population diversity 
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markers and haplotypes worldwide is necessary to accurately interpret disease association data 
from different patient populations. 
We  therefore  performed a  p o p u l a t i o n  g e n e t i c  s t u d y  o f  t h e   BDNF  genomic  region  to 
determine whether population dynamics could explain the inconsistent psychiatric association 
findings. Our data provide evidence for substantial population diversity at the BDNF locus, as 
well as two putative selection events acting on BDNF alleles, that have significant implications 
for disease association studies of this gene.  
 
Materials and Methods 
Subjects  
The study received approval from all appropriate Institutional Review Boards. DNA from 
the following collections was utilized: 12 multiplex pedigrees (93 individuals) obtained from the 
Centre  d’Etudie  Polymorphisme  Humain  (CEPH)  repository
27,28,  the  HGDR-CEPH  Human 
Genome  Diversity  Cell  Line  Panel  consisting  of  1064  individuals  from  57  worldwide 
populations
29, and 31 parent-child trios from the Yoruba people of Ibadan, Nigeria. The CEPH 
sample overlaps by 50% the HapMap European (CEU) sample
30. 
 
SNP Genotyping  
SNPs were selected from the dbSNP database (http://www.ncbi.nlm.nih.gov/SNP/), from 
our previous study
11, and from the former Celera Discovery System database. Genotyping was 
performed  by  Sequenom  MassARRAY  (San  Diego,  CA)  mass  spectrometry  as  described 
previously
11. SNP genotype data was subjected to the following quality control criteria prior to 
analyses: 1) >86% of attempted genotypes were successful (average 97% CEPH, >99% HGDR 
panel, 98% Yoruban), 2) founder alleles were in Hardy-Weinberg equilibrium (goodness of fit Running title: BDNF population diversity 
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test P>0.05), 3) <2% of transmitted alleles had Mendelian inheritance errors, and 4) minor allele 
frequency >2%.  
 
Haplotype Genealogy and Global Diversity 
Twelve  SNPs  within t h e  BDNF c o d i n g  r e g i o n  w e r e  g e n o t y p e d  i n  t h e  H G D R -CEPH 
Human Diversity Panel, 31 Yoruban parent-child trios, and 12 CEPH pedigrees. SNP identifiers 
are provided in Table S2. Maximum-likelihood  expectation  (MLE)  haplotypes comprising  the 
SNPs were reconstructed using an expectation maximization (EM) algorithm using data from all 
populations together to minimize artifact separation of the populations. SNP ancestral alleles 
were p r e d i c t e d  from  consensus  genotypes  from  chimpanzee,  gorilla,  and  orangutan D N A .  
Haplotype frequencies were determined for Africa, Asia, and Europe continental groups using 
all chromosomes that could be definitively classified into one of the groups (364 African, 444 
Asian, and 418 European chromosomes).  
The  Sweep  program  (P.  Varilly,  B.  Fry,  and  P.  Sabeti; 
http://www.broad.mit.edu/mpg/sweep/) was used to create BDNF haplotype genealogical trees 
for the three major continental regions using all classifiable chromosomes. A map of global 
diversity of BDNF haplotypes was created by displaying pie charts representing the calculated 
haplotype frequencies for each population on a world map using the Diaspora software program 
(B. Fry, unpublished software). Fixation index (FST) values to assess population differentiation 
were calculated using Weir-Hill unbiased estimator
31 for SNPs that were polymorphic in at least 
one population in the HapMap Phase II (release 21) dataset
32. Population comparisons were 
performed  by  calculating  FST v a l u e s  separately  for  the  HapMap  European  (CEU),  African 
(Yoruban - YRI), and Asian (Chinese and Japanese – CHB/JPT) populations. Significance of 
the FST values was determined by comparison to HapMap data. 
 Running title: BDNF population diversity 
 
 
6 
Long-Range Haplotype Test  
The  Long-Range  Haplotype  (LRH)  test
33  was  used  to  examine  evidence  for  recent 
positive selection at BDNF. Genotype data were utilized from 68 SNPs (Table S2) spanning 
500kb of the BDNF genomic region genotyped in 12 CEPH pedigrees, as well as genotype data 
from  the I n t e r n a t i o n a l  HapMap  Project  data  release  16
30.  Haplotype  blocks  were  defined 
according to Gabriel et al. 2002
34. MLE haplotypes were reconstructed using an EM algorithm. 
The LRH test detects evidence of an allele’s recent and rapid rise in prevalence in a population, 
based on disparity in the allele age estimated from its high frequency (characteristic of an old 
allele)  and  its  long-range  LD  (characteristic  of  a  young  allele). L o n g -range  association  was 
measured by extended haplotype homozygosity (EHH)
33. For a population of individuals sharing 
allele ‘t’, EHH at a distance ‘x’ from the locus is the probability that two random chromosomes 
carrying the allele are identical by descent for the entire interval from the locus to ‘x’. Correction 
for local variation in recombination rates was performed using the relative EHH (REHH), the 
factor by which EHH decays on the tested allele compared to all other alleles at a locus. The 
REHH and EHH were corrected by matching genetic distances of the loci using recombination 
rates from HapMap data. Decay of the extended ancestral haplotype on which the tested allele 
arose was visualized using the Bifurcator program (B. Fry; http://benfry.com/bifurcator/).  
 
Results 
Global diversity of BDNF SNPs 
Analysis  of  BDNF d i v e r s i t y  focused  on  the  Val66Met  polymorphism  (rs6265)  and  11 
other SNPs within the BDNF coding region that together encompass the region containing all 
BDNF variants reported to be associated with BP (Val66Met, a functional repeat polymorphism 
located 1kb upstream of exon 5
35, 36, and a coding region haplotype
11). All 12 SNPs had sizeable 
allele f r e q u e n c i e s  d i f f e r e n c e s  b e t w e e n  Europe,  Asia,  and  Sub-Saharan  Africa c o n t i n e n t a l  Running title: BDNF population diversity 
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groups. Notably, the derived Met allele of the Val66Met polymorphism (hereafter referred to as 
Met66)  increased  in  frequency  from 0 . 5 5 %  t o  1 9 . 9 %  a n d  4 3 . 6 %  frequency  in  Sub-Saharan 
Africa, Europe, and Asia, respectively. Subsequent analysis of SNP distributions in each of 58 
global  populations  identified  considerable  diversity  in  allele  frequencies  (Table  S3), 
corroborating the trend observed in the continental groups. The Met66 frequency varied widely 
from 0-72% among populations (Figure 1), being virtually absent in all Sub-Saharan African and 
some American indigenous populations. 
Population diversity of Val66Met was supported by comparison of FST values from the 
International HapMap Project. FST analyses detect population genetic differences that originated 
after the divergence of human populations, roughly 50,000 to 75,000 years ago
37. Comparison 
of FST values of all non-synonymous SNPs in the genome, including Val66Met, to the distribution 
of all HapMap SNPs (synonymous and non-synonymous) determined that the Val66Met FST 
value (0.149) was in the 99.8th percentile and ranked 25th among >11,000 non-synonymous 
SNPs  in  the  genome.  This  polymorphism  also  had  high  FST v a l u e s  w h e n  c o m p a r i n g  t h e  
HapMap European, Asian (Chinese and Japanese treated as a single population), and Yoruban 
populations  to  each  other  (European  vs.  Asian, FST =  0 . 1 8 6 ,  86
th p e r c e n t i l e ;   European  vs. 
Yoruban, FST = 0.168, 75
th percentile; Asian vs. Yoruban, FST = 0.439, 94
th percentile).  
Figure 1 about here 
 
Global diversity of BDNF haplotypes 
We  subsequently  examined  population  diversity  of  haplotypes  comprised  of  the  12 
BDNF SNPs. Eleven haplotypes observed above 2% frequency in at least one of the Europe, 
Asia, and Sub-Saharan Africa continental groups had clear frequency differences between the 
three groups (Figure 2A and Table S3). Met66 (“T” allele) was present on two haplotypes each 
exclusive to Asia and Europe (haplotype-6 and -7, respectively), and was not present on any Running title: BDNF population diversity 
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Sub-Saharan African haplotypes. Haplotype-7 corresponds to the Met66-carrying haplotype we 
previously found associated with BP
11. BDNF haplotype genealogical trees were constructed for 
each  of  the  continental  groups  to  clarify  the  population  genetic  structure ( F i g u r e  2B).  The 
number and length of branches in the three trees were comparable, indicating similar history 
and  mutational  distance  from  the  ancestral  haplotype.  An  exception  was  the  branch  that 
contains haplotypes-6 or -7 in the Asian or European trees, respectively, which was shorter in 
the African tree due to having only one haplotype (haplotype-2). Haplotype-6 was found to be 
ancestral to haplotype-7, differing only in the allele of rs2049045 (of the SNPs we examined), 
with haplotype-6 having the ancestral “G” allele and haplotype-7 having the derived “C” allele 
(Figure 2A).  
Figure 2 about here 
Examination of BDNF haplotypes among the global populations identified considerably 
different h a p l o t y p e  s t r u c t u r e  a n d  f r e q u e n c i e s  b e t w e e n  p o p u l a t i o n s ,  but  generally  similar 
patterns within a geographic group (Figure 2C and Table S3). Of the Met66-carrying haplotypes, 
haplotype-6 ranged  from  2-70% frequency i n As i an,  Oc eani a,  and s ome Cent r al  and Sout h 
American  populations,  whereas  haplotype-7  was  at  2-29%  frequency  in  European,  North 
African, Middle Eastern, and some Asian (solely Pakistani) populations. All together, these data 
further  point  toward  considerable  diversity  of  BDNF p o l y m o r p h i s m s  a m o n g  w o r l d w i d e  
populations. 
 
Evidence for positive selection of haplotypes spanning the BDNF region 
The  observed  population  genetic  differences  in  BDNF  alleles  may  be  due  to  local 
selection,  which  can  have  large  effects  on  LD  and  thereby  impact  association  studies.  We 
therefore looked for evidence of selection across the BDNF genomic region within European-
derived CEPH pedigrees using the Long-Range Haplotype (LRH) test
33. This method detects Running title: BDNF population diversity 
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evidence for more recent positive selection (<30,000 years old) compared to the FST analyses 
above. The LRH test identifies variants that appear to have recently arisen in a population, 
based on the extent of the surrounding ancestral chromosome, but that are prevalent in the 
population, suggesting natural selection may have caused a rapid rise in the allele’s frequency.  
We examined 68 SNPs across a 500kb region on chromosome 11 spanning the BDNF, 
LIN7C, LGR4, and CCDC34 genes. A common 45% frequency haplotype located 5’ of BDNF 
had evidence for an extended ancestral haplotype, as measured by relative extended haplotype 
homozygosity (REHH) (see Methods). The long-range haplotype extending from this haplotype 
covers the entire genomic region examined (Figure S1A). The haplotype carries the Val66 allele 
and  corresponds  to  haplotype-11  in  Figure  2.  Further e v i d e n c e  f o r  s e l e c t i o n  o f  t h e  BDNF 
haplotype was obtained by comparison of its REHH and frequency to the empirical distribution 
of chromosome 11 haplotypes from the HapMap European (CEU) data
30. The haplotype REHH 
value was above the 99
th percentile when compared to 1,652 chromosome 11 haplotypes with 
comparable frequencies (40-45%) (Figure S1B; uncorrected P = 4.6 x 10
-4). This result indicates 
that the haplotype has more extensive LD given its frequency than expected under neutrality, 
which is suggestive of selection at the BDNF genomic region. Selection on this Val66-carrying 
haplotype is unlikely to explain the high Val66Met FST values above, since the elevated Met 
allele frequency outside of Africa appears to drive the FST result.  
 
Discussion  
Our study to gain insight into the potential impact of population diversity on association 
studies of BDNF revealed several lines of evidence suggesting the BDNF genomic region is not 
neutrally  evolving.  First,  prominent  differences  were  found  among  global  populations  in 
frequencies of the Val66Met variant and BDNF haplotypes. The derived Met66 allele ranged 
considerably  from  0-72%  frequency  across  populations,  and  exists o n  d i f f e r e n t  p o p u l a t i o n -Running title: BDNF population diversity 
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specific haplotypes in Europeans and Asians. This substantial global diversity was supported by 
FST analyses in the HapMap populations, in which the Val66Met FST value was above the 99
th 
percentile in the distribution of all SNPs in the genome. This putative selection signal appears to 
be  driven  by  the  derived  Met  allele  and  reflects  its  rise  in  frequency  across  Sub-Saharan 
African, European, and Asian populations. Second, the presence of young polymorphisms at 
high frequency in European-derived populations is indicative of a more recent selection event. A 
long-range haplotype detected at the BDNF locus carries the Val allele of Val66Met, and thus 
appears to be a different selection event than the Met allele signal identified in FST analyses. 
These data suggest that selection may have been operating on more than one BDNF allele or 
haplotype. It is important to note, however, that due to extensive LD, the long-range haplotype 
extends throughout the entire region examined, spanning BDNF, LIN7C, LGR4, and CCDC34, 
and it is therefore not possible to distinguish from which gene this selection event originates. 
Given the critical functions of BDNF in neuronal survival and plasticity
1,2, selection may increase 
the prevalence of new variants that increase fitness by altering any of these functions. 
The global diversity of Met66 and its rapid rise across Sub-Saharan African, European, 
and  Asian  populations  is  intriguing  given  its  seemingly  detrimental  effect  on  neuronal  and 
cognitive  function
4-10.  In  addition,  Met66  is  at  lower  frequency  in  BP  and  other  psychiatric 
patients compared to controls (except in eating disorders), rather than at higher frequency as 
expected  given  its  apparently  deleterious  function.  As  BDNF h a s  d i v e r s e  r o l e s  i n  n e u r a l  
development,  cell  survival,  and  synaptic  plasticity
1,2,  however,  it  is  possible  that  Met66  has 
pleiotropic effects, some detrimental and some beneficial. As discussed by Lipsky and Marini
2, 
downregulation of synaptic plasticity by Met66, particularly in excitatory glutamatergic circuits, 
may be protective against psychiatric disorders, despite Met66 being associated with reduced 
cognitive performance
4, 6-10. Running title: BDNF population diversity 
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 The observed population genetic differences in BDNF have implications for interpreting 
the conflicting association literature for psychiatric disorders. If Val66Met is a true risk variant, its 
presence  on  different  haplotypic  backgrounds  may  produce  different  association  patterns  in 
different  populations,  which c o u l d  a c c o u n t  f o r  t h e  i n c o n s i s t e n t  a s s o c i a t i o n  s i g n a l s  b e t w e e n  
studies. Alternatively, if Val66Met does not have a direct role in disease, but rather is in LD with 
the true associated allele to varying degrees in different populations, inconsistent association 
findings with Val66Met could also result due to population differences in LD patterns. It will be 
crucial to consider population genetic information when carrying out future disease association 
studies of this locus.   
In conclusion, we have uncovered substantial global diversity and evidence for positive 
selection  of  the  BDNF V a l 6 6 M e t  p o l y m orphism  and  BDNF  region  haplotypes.  The  unusual 
genetic  diversity  at  the  locus  may  explain t h e   varying r e s u l t s  between p r e v i o u s  a s s o c i a t i o n  
studies using different patient populations. Further studies that take into account the population 
diversity in the BDNF genomic region are required to elucidate whether this gene has a role in 
major mental illness. 
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Figure Legends 
 
Figure 1  BDNF Val66Met allele frequencies in global populations.  Frequencies of the Val66 
allele (gray) and Met66 allele (black) are shown for each of the 57 populations in the HGDR-
CEPH Human Diversity Panel and for CEPH pedigrees.  
 
Figure 2  Global diversity and genealogy of BDNF haplotypes. (A) BDNF  haplotypes comprised 
of 12 coding region SNPs observed in European, Asian, and Sub-Saharan African continental 
groups. Val66Met/rs6265 is indicated by an arrow (C = Val, T = Met). Shown is the ancestral 
haplotype (top) and eleven haplotypes above 2% frequency in at least one of the continental 
groups (dots = ancestral alleles, nucleotide letters = derived alleles), with frequencies shown to 
the right.  (B) BDNF haplotype genealogical trees in European, Asian, and Sub-Saharan African 
groups.  Trees  are  rooted  at  the  predicted  ancestral  haplotype ( square  at  top)  and  each 
haplotype is shown as a square of size proportional to frequency and branch length proportional 
to  mutational  distance.  Unfilled  squares  indicate  unobserved  haplotypes  that  are  necessary 
links.  (C)  BDNF h a p l o t y p e  f r e q u e n c i e s  i n  g l o b a l  p o p u l a t i o n s  a r e  i n d i c a t e d  b y  p i e  d i a grams 
placed relative to population geographic locations.  
 